Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 1186Terminated 377Recruiting 271Unknown 160Active not recruiting 160Withdrawn 90Not yet recruiting 49Suspended 15Enrolling by invitation 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Gastrointestinal 91Breast 51Genitourinary 44Gynecologic 30Thoracic 29Lymphoid 25Other hematologic neoplasm 21CNS 20Tumor-Agnostic 17Head & Neck 17Other solid neoplasm 11Sarcoma 8Endocrine 7Dermatologic 6Plasma cell 4Myeloid 4Other 3NET 2Classical hematology 2

Conditions

Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Prostatic Neoplasms, Castration-Resistant 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

ibrutinib 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1Melphalan 1JNJ-64619178 1JNJ-64264681 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Myeloid × Clear all
NCT06788509 2026-06-05

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Janssen Research & Development, LLC

Phase 1 Enrolling by invitation
120 enrolled
GenitourinaryLymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Prostatic Neoplasms, Castration-Resistant

NCT04093570 2025-10-31

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Taiho Oncology, Inc.

Phase 2 Enrolling by invitation
332 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT02646839 2025-05-04

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Pediatric Transplantation & Cellular Therapy Consortium

Phase 2 Enrolling by invitation
50 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05674539 2025-02-10

Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Enrolling by invitation
200 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡